The comparator will be Placebo, which will be formulated as tablets, and will contain the protocol mentioned clinical trials

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis

This study is testing a new medicine, Saroglitazar Magnesium, for people with Primary Biliary Cholangitis (PBC). Researchers want to see if it improves liver test results and is safe. Some people will get the medicine, others will get a dummy pill.